The introduction of new digital technologies in various business sectors leads to numerous changes in the business environment. One of the most tangible such changes is the transformation in the pharmaceutical industry produced by the expanded application of cloud systems, artificial intelligence, and machine learning.
The use of autonomous devices and systems is vital in producing high-quality medicines at lower cost and in less time. The research and development phase for developing a new pharmaceutical product is very long and expensive compared to conventional products, and the use of advanced technologies in this process can bring huge benefits to the pharmaceutical industry, while providing an opportunity for regulatory authorities to track all stages of the process with greater transparency and less effort.
Ding B (2018) Pharma industry 4.0: literature review and research opportunities in sustainable pharmaceutical supply chains. Process Saf Environ Prot 119:115–130. DOI: 10.1016/j.psep.2018.06.031
Jankowski A (2017) The concept of complex system. In: Interactive granular computations in networks and systems engineering: a practical perspective. Springer, Cham, pp 55–62. DOI: 10.1007/978-3-319-57627-5
Ratasich D, Khalid F, Geissler F, et al. (2019) A roadmap toward the resilient internet of things for cyber-physical systems. IEEE Access 7:13260–13283. DOI: 10.1109/ACCESS.2019.2891969
Chaâri R, Ellouze F, Koubâa A, et al. (2016) Cyber-physical systems clouds: a survey. Comput Netw 108:260–278. DOI: 10.1016/j.comnet.2016.08.017
Reinhardt IC, Oliveira JC, Ring DT (2020) Current perspectives on the development of industry 4.0 in the pharmaceutical sector. J Ind Inf Integr 18:100131 DOI: 10.1016/j.jii.2020.100131
Erlanson DA, Davis BJ, Jahnke W (2019) Fragment-based drug discovery: advancing fragments in the absence of crystal structures. Cell Chem Biol 26(1):9–15. DOI: 10.1016/j.chembiol.2018.10.001
Rĺache Brazil, The Pharmaceutical Journal, Dec 2007; Available at: https://pharmaceutical-journal.com/
AI in the Pharma Industry: Current Uses, Best Cases, Digital Future, 2021; Available at: https://pharmanewsintel.com/news/ai-in-the-pharma-industry-current-uses-best-cases-digital-future
Top AI Use Cases In Pharma and Bio medicine, 2020; Available at: https://usmsystems.com/ai-in-pharma-and-biomedicine/
Gartner Forecasts Worldwide Artificial Intelligence Software Market to Reach $62 Billion in 2022, 2021; Available at: https://www.gartner.com/en/newsroom/press-releases/2021-11-22-gartner-forecasts-worldwide-artificial-intelligence-software-market-to-reach-62-billion-in-2022#:~:text=Gartner%20Forecasts%20Worldwide%20Artificial%20Intelligence%20Software%20Market%20to%20Reach%20%2462%20Billion%20in%202022,-Market%20Growth%20Will
Laman F (2021) Pharmaceuticals Data Analysis by Machine Learning. 10. ISSN: 2319-7463.
Jang HY, Song J, Kim J, et al. (2022) Machine learning-based quantitative prediction of drug exposure in drug-drug interactions using drug label information. npj Digital Medicine. 5. DOI: 10.1038/s41746-022-00639-0.
Lo YC, Rensi SE, Torng W, Altman RB (2018) Machine learning in chemoinformatics and drug discovery. Drug Discov Today 23(8):1538–1546. DOI: 10.1016/j.drudis.2018.05.010
How big data can revolutionize pharmaceutical R&D, 2013; Available at: https://www.mckinsey.com/industries/life-sciences/our-insights/how-big-data-can-revolutionize-pharmaceutical-r-and-d
Reza EH, Reza B, Anant P (2021) From Industry 4.0 to Pharma 4.0. DOI: 10.1007/978-3-030-58675-1_4-1.
Samsa G, Samsa L (2019) A guide to reproducibility in preclinical research. Acad Med 94(1):47-52. DOI: 10.1097/ACM.0000000000002351
Lapinlampi N, Melin E, Aronica E, et al. (2017) Common data elements and data management: remedy to cure underpowered preclinical studies. Epilepsy Res 129:87–90. DOI: 10.1016/j.eplepsyres.2016.11.010
Computers in Preclinical development, 2018; Available at: https://www.clinskill.com/computers-in-preclinical-development/
Reinhardt IC, Oliveira JC, Ring DT (2020) Current perspectives on the development of industry 4.0 in the pharmaceutical sector. J Ind Inf Integr 18:100131. DOI: 10.1016/j.jii.2020.100131
Jarada TN, Rokne JG, Alhajj R (2020) A review of computational drug repositioning: strategies, approaches, opportunities, challenges, and directions. J Chem 12(1):1–23. DOI: 10.1186/s13321-020-00450-7
The Increasing Use Of AI In The Pharmaceutical Industry, 2020; Available at: https://www.forbes.com/sites/cognitiveworld/2020/12/26/the-increasing-use-of-ai-in-the-pharmaceutical-industry/?sh=72b132fd4c01
Big pharma is using AI and machine learning in drug discovery and development to save lives, 2022; Available at: https://www.insiderintelligence.com/insights/ai-machine-learning-in-drug-discovery-development/
Georgiev S, Priftis S, Grigorov E. (2021) Blockchain in the Logistics of Health Technologies. Proceedings of the Information Systems and Grid Technologies 2933:189-202. DOI: https://doi.org/10.6084/m9.figshare.16540020.v1
Email this article (Login required) 
